Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony

Virology

Volumn 279, Issue 1, 2001, Pages 185-200

  Belshan, Michael ^a   Baccam, Prasith ^a   Oaks, J Lindsay ^b   Sponseller, Brett A ^a   Murphy, Sean C ^a   Cornette, James ^a   Carpenter, Susan ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

EIAV; Evolution; Persistence; Quasispecies; Rev; Variation

Indexed keywords

REGULATOR PROTEIN; REV PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; EQUINE INFECTIOUS ANEMIA VIRUS; EVOLUTION; FEVER; GENETIC SELECTION; GENETIC VARIABILITY; HORSE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN TRANSPORT; SPECIES DISTRIBUTION; VIRUS INFECTION;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS;

EID: 0035916015     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0696     Document Type: Article

References (55)

1. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus
2. PCR bias toward the wild-type k-ras and p53 sequences: Implications for PCR detection of mutations and cancer diagnosis
3. Biological characterization of Rev variation in equine infectious anemia virus
4. Identification of a novel cellular cofactor for the rev/rex class of retroviral regulatory proteins
5. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus
6. Role of the host immune response in selection of equine infectious anemia virus variants
7. Mechanism of action of regulatory proteins encodedby complex retroviruses
8. Basic concepts in RNA virus evolution
9. Viral quasispecies
10. CRM1 is an export receptor for leucine-rich nuclear export signals
11. Identification of the activation domain of equine infectious anemia virus rev
12. Rapid detection of bovine viral diarrhea virus by using RNA extracted directly from assorted specimens and a one-tube reverse transcription PCR assay
13. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process
14. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein
15. Primers are decisive in sensitivity of PCR
16. A coalescent estimator of the population recombination rate
17. RNA virus populations as quasispecies
18. Viral RNA export
19. Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev
20. Optimization of DNase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR
21. Fidelity of human immunodeficiency virus type 1 reverse transcriptase in copying natural RNA
22. Equine infectious anemia: Current knowledge
23. Equine infectious anemia: Prospects for control
24. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual
25. Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene
26. Retroviral mutation rates and A-to-G hypermutation during different stages of retroviral replication
27. Viremia and immunological responses in horses infected with equine infectious anemia virus
28. Recurrences of equine infectious anemia
29. Antigenic drift of equine infectious anemia virus in chronically infected horses
30. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony
31. Posttranscriptional effector domains in the rev proteins of feline immunodeficiency virus and equine infectious anemia virus
32. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus
33. Characterization of EIAV immunogenicity during persistent infections: Humoral responses and antigen targets
34. HIV mutation rate
35. Equine infectious anemia virus is found in tissue macrophages during subclinical infection
36. Interaction of the human immunodeficiency virus type 1 rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids
37. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus
38. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends
39. Genomic alterations associated with persistent infections by equine infectious anemia virus, a retrovirus
40. Antigenic variation and lentivirus persistence: Variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV
41. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli
42. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection
43. Bias in template-to-product ratios in multitemplate PCR
44. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection
45. Exportin 1 (Crm1p) is an essential nuclear export factor
46. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 rev protein in yeast
47. Kinetic bias in estimates of coastal picoplankton community structure obtained by measurements of small-subunit rRNA gene PCR amplicon length heterogeneity
48. Bias caused by template annealing in the amplification of mixtures of 16S rRNA genes by PCR
49. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism
50. Sequence-specific RNA binding by the HIV-1 Rev protein
51. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: Insertions/duplications at the principal neutralizing domain